Disasters & accidents, Consumer, Health · 12 h
7 storiesFire at Ustuu-Khuree Buddhist monastery complex in Tuva put out; no injuries
A fire broke out on 7 October at the Ustuu-Khuree Buddhist monastery complex in Tuva, about 5 km from the town of Chadan. Emergency services localized the blaze and later extinguished it; the MChS reported an area of 468 sq m, while earlier…
MFDS approves Hanmi's EPPE, Korea's first homegrown GLP-1 obesity drug
Korea's Ministry of Food and Drug Safety approved Hanmi Pharmaceutical's EPPE auto-injector (efpeglenatide) on Oct 7, the first domestically developed GLP-1 obesity drug and the country's 45th homegrown new drug. The injectable is indicated…
Kremlin: Russia informed WHO of Irkutsk region situation after worker death
Kremlin spokesman Dmitry Peskov said Russia has informed the World Health Organization about the situation in the Irkutsk region, following the death of an employee of the Irkutsk anti-plague institute. Peskov also said he had no informatio…
Boy falls into Lake Biwa at Nagahama Port, taken to hospital in cardiopulmonary arrest
A boy fell into Lake Biwa at Nagahama Port in Nagahama City, Shiga Prefecture, on the afternoon of October 7 and was taken to hospital in cardiopulmonary arrest, police and fire officials said. One outlet reported he was a 12-year-old first…
US reports largest state-level measles outbreak in over 30 years
The United States is experiencing its largest state-level measles outbreak in more than 30 years, according to Chinese media reports. Pennsylvania health authorities reported 1,004 confirmed measles cases and five deaths in 2026 as of Octob…
WHO says more than 170 million children and adolescents worldwide live with obesity
The World Health Organization says more than 170 million children and adolescents aged 5 to 19 worldwide have been diagnosed with obesity, with prevalence in that age group rising fourfold since 1990, from 2% to about 8%. The WHO issued gui…
Betta Pharmaceuticals unit's BPI-572270 capsule wins US FDA clinical trial clearance
Betta Pharmaceuticals said the US FDA has approved a clinical trial application for BPI-572270 capsules, filed by its wholly-owned subsidiary Jingyao Biology, for advanced solid tumours. The company described the drug as a self-developed pa…